Vol. 8 (03) pp. 469-477 DOI: 10.21474/IJAR01/10651

PULMONARY MANIFESTATIONS DURING SPONDYLARTHRITIS

, , , , , and
  • Rheumatologic Department, Military Hospital of Moulay Ismail, Meknes - Morocco.
17 Downloads 77 Views
Crossref

Download Full Paper (PDF)

Abstract

Introduction: Pleuropulmonary involvement in spondylarthritis has long been considered a rare and late manifestation of this group of diseases because of its asymptomatic nature and the failure of chest X-ray to detect early lung injury. However, with the advent of CT scanning, a wide variety of sub-clinical lung lesions that were not detectable on standard radiography have been objectified. Objectives: Research the correlations between lung involvement and the different characteristics and types of spondylarthritis. Materials and Methods: This is a retrospective cohort-type observational epidemiological study, conducted over a 3-year period. 133 patients with spondylarthritiswere included. All had a detailed clinical examination, chest X-ray, respiratory function tests and chest CT scan. Results: 133 patients with spondyloarthropathies; 57 spondyloarthritis, 54 psoriatic arthritis and 22 IBD-associated spondyloarthritis. M/F sex ratio of 1.14. Chest CT scan revealed abnormalities in 58 patients (43.6%) with 13 symptomatic respiratory patients, whereas the standard chest X-ray was abnormal in only 19 cases. Multivariate analysis showed factors associated with CT abnormalities in patients over 60 years of age, with dactylitis, and cervical stiffness. Factors associated with ventilatory abnormalities have also been found in patients over 60 years of age, cervical stiffness, coxitis, inflammatory syndrome, and osteoporosis. No influence of the type of spondylitis was found on the presence or type of lung involvement (p=0.230). Conclusion: This study allowed us to detect certain factors associated with lung damage, revealed early on thoracic CT and EFR, in patients with SpA. It would be judicious to propose this examination in patients with functional respiratory signs even if the standard radiography is normal, even for a wider screening in any SpA patient even asymptomatic.

Keywords

Article Analytics

References

  1. El Maghraoui A. Pleuropulmonary involvement in ankylosing spondylitis. Joint Bone Spine 2005;72:496?502.
  2. Ozlem Senocak, Metin Manisalı, Dinc Ozaksoy, Can Sevinc, Elif Akalın. Lung parenchyma changes in ankylosing spondylitis: demonstration with high resolution CT and correlation with disease duration.
  3. Kiris A, Ozgocmen S, Kocakoc E, Ardicoglu O. Lung findings on high resolution CT in early ankylosing spondylitis. Eur J Radiol. 2003 Jul ;47(1) :716.
  4. M. Fenlon, I. Casserly, S. M. Sant, and E. Breatnach, ?Plain radiographs and thoracic high-resolution CT in patients with ankylosing spondylitis,? American Journal of Roentgenology, vol. 168, no. 4, pp. 1067?1072, 1997.
  5. El Ghoul, N. Rouetbi, S. Joobeur, N. Skhiri, S. Cheikh Mhamed, A. El Kamel. Spontaneous pneumothorax associated with ankylosing spondylitis. Revue de pneumologie clinique (2012) 68, 266?268.
  6. Rosenow E, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc. 1977 Oct ;52(10) :641-9.
  7. Casserly IP, Fenlon HM, Breatnach E, Sant SM. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis--correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol. 1997 Jun;36(6):677-682.
  8. Machado-Pinto J, dos Santos M, Bavoso D. Psoriasis: new comorbidities. An Bras Dermatol 2016 Jan-Feb;91(1):8e14
  9. Chiang YY, Lin HW. Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan. J Eur Acad Dermatol Venereol 2012 Jan;26(1):59e65.
  10. Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 2013 Oct;149(10):1173e9.
  11. Li X, Kong L, Li F ,et al. Association between psoriasis and chronic obstructive pulmonary disease: asystematic review and meta-analysis. PLoS One 2015 Dec 23;10(12):e0145221.
  12. Wanat KA, Schaffer A, Richardson V ,et al. Sarcoidosis and psoriasis: a case series and review of the literature exploring co-incidence vs coincidence. JAMA Dermatol 2013 Jul;149(7):848-52.
  13. Nikolopoulou M, Katsenos S, et al. Pulmonary sarcoidosis associated with psoriasis vulgaris: coincidental occurrence or causal association? Case report. BMC Pulm Med 2006;6:26-7.
  14. WONG K, GLADMAN DD, HUSTED J, LONG J, FAREWELL VT: Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and causes of death. Arthritis Rheum 1997; 40: 1868-72.
  15. Zhao Y, Wang J, Liu Z, Lin H, Shi Y, Sun X. Pulmonary dysfunction in 114 patients with inflammatory bowel disease. Medicine (Baltimore). 2017;96(18), e6808
  16. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore). 1993;72(3):151-83.
  17. MahadevaR,WalshG,FlowerCD,ShneersonJM.Clinicaland radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J. 2000;15:41-8.
  18. Raj AA, Birring SS, Green R, Grant A, de Caestecker J, Pavord ID. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med. 2008;102(5):780-5.
  19. Brassard P, Vutcovici M, Ernst P, et al. Increased incidence of inflammatory bowel disease in Qu?bec residents with airway diseases. Eur Respir J. 2015;45(4):962-8.
  20. Vutcovici M, Brassard P, Bitton A. Inflammatory bowel disease and air- way diseases. World J Gastroenterol. 2016;22(34):7735-41.
  21. Tulic M, Piche T, Verhasselt V. Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. Clin Exp Allergy. 2016;46(4):519-28.
  22. Ji X-Q, Wang L-X, Lu D-G. Pulmonary manifestations of inflammatory bowel disease. World J Gastroenterol WJG. 2014;20:13501?13511.
  23. Casey MB, et al. Noninfectious lung pathology in patients with Crohn?s disease. Am J Surg Pathol. 2003;27:213?219.
  24. Ozlem Senocak, Metin Manisalı, Dinc Ozaksoy, Can Sevinc, Elif Akalın. Lung parenchyma changes in ankylosing spondylitis: demonstration with high resolution CT and correlation with disease duration.
  25. Abdellah El Maghraoui. Pleuropulmonary involvement in ankylosing spondylitis. Revue du rhumatisme 72 (2005) 1263?126.
  26. Remzi A, Senay O, Ahmet S, Selda S, Meltem T, Levent K, Huseyin O. Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients? daily life. Clin Rheumatol (2005) 24 : 22?28.
  27. Kiris A, Ozgocmen S, Kocakoc E, Ardicoglu O. Lung findings on high resolution CT in early ankylosing spondylitis. Eur J Radiol. 2003 Jul ;47(1) :716.
  28. Baser S, Cubukcu S, Ozkurt S, et al. Pulmonary involvement starts in early stage ankylosing spondylitis. Scand J Rheumatol 2006 ;35 :325?327.
  29. Turetschek K. Ebner W. Fleischmann D. Wunderbaldinger P. Erlacher L. end al. Early pulmonary involvement in ankylosing spondylitis: assessment with thin-section clinical radiology. 2000 Aug;55(8):632-6.
  30. Casserly IP, Fenlon HM, Breatnach E, Sant SM. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis--correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol. 1997 Jun;36(6):677-682.
  31. Berdal G, Halvorsen S, Van Der Heijde D, et al. Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in Matched population controls and is associated with impaired spinal mobility: a comparative study. Arthritis Res Ther 2012 ;14 : R19.
  32. Daniel Wendling, C?dric Lukas, Julien Paccou, Pascal Claudepierre, Laurence Carton, Bernard Combe, Philippe Goupille, Francis Guillemin, Christophe Hudry, Corinne Miceli-Richard, Maxime Dougados. Recommandations de la soci?t? fran?aise de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite. Revue du rhumatisme 81 (2014 )6-15.
  33. Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis2006; 65:442?52.
  34. Ozgocmen S, Akgul O, Altay Z, et al. Expert opinion and key recommendations for the physical therapy and rehabilitation of patients with ankylosingspondylitis. Int J Rheum Dis 2012; 15:229?38.
  35. Dougados M, Braun J, Szanto S, et al. Efficacy of etanercept on rheumatic signsand pulmonary function tests in advanced ankylosing spondylitis: results ofa randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis2011 ;70 :799?804.
  36. Conway R, Low C, Coughlan R, et al. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials. BMJ Br Med J March 2015;350:h1269.

How to Cite This Article

Tarik Youssoufi, Mehdi Boudhar, Fatima Zahra Haddani, Oulahri Soumia, Youssef El. Jebbouri, Abdelhafid Guich and Hasna Hassikou (2020); PULMONARY MANIFESTATIONS DURING SPONDYLARTHRITIS, Int. J. of Adv. Res., 8 (03), 469-477, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/10651

Corresponding Author

tarik youssoufi

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.